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Brewster angle microscopy (BAM)
Polarization modulation infrared reflection ab-
sorption spectroscopy (PM-IRRAS)The effects of selected statins on the structure and properties of lipidmembranes composed of zwitterionic (1,2-
dimyristoyl-sn-glycero-3-phosphocholine, DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine, DMPE)
or anionic (1,2-dimyristoyl-sn-glycero-3-phospho-L-serine, DMPS) lipids were studied for the first time by Lang-
muir technique combinedwith polarizationmodulation infrared reflection absorption spectroscopy (PM-IRRAS)
and Brewster angle microscopy (BAM). The interactions of statins of different hydrophobicity: pravastatin,
fluvastatin, and cerivastatin with the polar region of the lipids forming the membrane were monitored by PM-
IRRAS and the changes of the overallmonolayer structure and organizationwere described on the basis of surface
pressure vs. area per molecule measurements and Brewster angle microscopy. Large differences in the action of
each of the statins on the lipid monolayers were observed and explained by their different hydrophobicity com-
binedwith the different degree of hydration of the lipid polar headgroups in themonolayer.Monolayer fluidizing
effect was connected with the interaction of statins in the headgroup region of themembrane affecting the orig-
inal hydrogen bonding in the lipid layers. The most hydrophilic pravastatin interacted only with the polar head
groups of the monolayer and affected the organization of the polar part of the lipid membrane by increasing
the headgroups hydration. In the case of DMPS, the contribution of electrostatic interactions between the nega-
tively charged headgroups and the drug was observed, and for this lipid especially strong dehydration effect of
cerivastatin was revealed. It facilitated the incorporation of the hydrophobic part of the drug into the nonpolar
region of the DMPS layer and in this case there was almost no fluidization of the layer. Strong dehydration effects
may be dangerous for the lipid membranes and may also be one of the reasons to avoid cerivastatin in the ther-
apies, despite its known efficacy especially in view of the large doses and prolonged application that are usually
needed.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Statins are the most common hypolipidemic drugs which act as
competitive inhibitors of 3-hydroxy-3-methyl-glutaryl-Coenzyme A
(HMG-CoA) reductase (HMG-CoA reductase), the enzyme which cata-
lyzes the rate-limiting step: the deacylation of HMG-CoA to CoA and
mevalonate in the cholesterol biosynthetic pathway [1–4]. One of the
mechanisms for controlling HMG-CoA reductase activity is the so-
called negative feedback [5]. Reductase activity decreases as the concen-
tration of mevalonate and thus cholesterol increases. Cholesterol is an
important lipid in membranes of higher eukaryotes and accounts for
~30–50% of the total plasma lipid content. The unique structure of.pl (D. Matyszewska),
. This is an open access article undercholesterol and its ability to organize into distinct membrane domains
contribute to the functional role of cholesterol in many processes e.g.
signal transduction, trafficking, and pathogenesis [6]. Cholesterol is
mainly produced in hepatocytes and from there it is transported
throughout the body systems using lipoproteins, LDL and HDL [7]. Too
high levels of LDL-cholesterol result in cardiovascular diseases and are
nowadays the primary cause of disability and premature death [8,9].
Several approaches to treat hypercholesterolemia have been used
worldwide since it represents a major risk for coronary heart disease.
Statins can be divided into those of natural and synthetic origin.
Pravastatin used in our study belongs to the first group, while
fluvastatin and cerivastatin are synthetic statins produced in biotechno-
logical processes (Fig. 1) [10]. Statins have various structures, however,
they all have the same pharmacophore group of the beta-hydroxy acid
chain. They differ in the substituents that determine their lipophilicity.
In their structure, statins are similar to the HMG-CoA molecule but
show greater affinity towards HMG-CoA reductase [11]. It is importantthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Structural formulas of phospholipids: A) DMPC; B) DMPE; C) DMPS; and statins: D) pravastatin; E) fluvastatin; F) cerivastatin.
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therapeutic target protein but also they can modify the properties of
the cell membranes, which would also cause alterations in the function
of membrane proteins by changing e.g. packing of the lipid molecules
around the proteins. An important direction of research on statins
should be, therefore, to understand the changes that may occur in the
lipid membrane under the influence of statins and factors that control
drug penetration through these membranes.
The statins' effect on lipid membranes remains underexplored and
the reports are scarce, since attention is focused rather on controlling
cholesterol levels or statins' role in processes related to cancer. Larocque
et al. discussed the interactions of fluvastatin with DMPC/DMPS
bilayered micelles (bicelles) studied with infrared spectroscopy and
NMR [12]. Fluvastatinwas found to enter the DMPC/DMPS bilayer inter-
face by interacting with the lipids' polar headgroups, while aromatic
moieties partitioned into the nonpolar part of the bilayer. Lipid segrega-
tion also took place between the anionic and zwitterionic lipids in the
membranes due to a preferential interaction of fluvastatin with DMPS.
The interaction of a series of statin molecules: pravastatin, mevastatin,
simvastatin, and fluvastatin with a phosphatidylcholine monolayer
immobilized on porous silica particles has been studied using a
biochromatographic approach (molecular chromatography) [13]. The
immobilized artificial membrane provided a biophysical model system
to study the binding of statin molecules to the lipid membrane.
Mevastatin, atorvastatin, simvastatin and fluvastatin exhibited higher
affinity towards the lipid monolayer surface than pravastatin. Thus,
these statins were proposed to efficiently cross the cellular membrane
without a transporter, simply by passive diffusion. Studies of mica sup-
ported lipid bilayers by atomic force microscopy have shown that
statins affect nanomechanical stability of the supported bilayer and in-
crease its heterogeneity [14]. The behavior of such membrane models
depends, however, on the properties of the solid support, which is not
present in the case of real membranes.
In this report we focus on showing how the contact with a solution
containing statins affects the organization of simple one-component
lipid layers (DMPC, DMPE or DMPS) treated as one leaflet of a lipid
membrane, which is free from any rigid support (Fig. 1). The composi-
tion of model membranes was chosen based on the differences in the
polar head group region properties. The lipids selected for the mono-
layer formation are the zwitterionic (DMPC, DMPE) and the negatively
charged (DMPS) lipids. These lipids represent the groups of phospho-
lipids, which are the main components of intestinal cell membranes,
where the absorption of the selected drugs takes place [15].
Our approach is novel in that the lipid monolayer formation by the
Langmuir technique at the air-solution interface allows the evaluation
of statin induced changes on themolecular level - in the lipid molecules
orientation and parts of the lipid interactingwith the drug. Thus, the im-
pact of those changes on the organization of the whole layer can beassessed. We selected 3 statins: pravastatin (PRA), fluvastatin (FLU)
and cerivastatin (CER) differing in structure and lipophilicity to be
added to the subphase (Fig. 1). The octanol–water partition coefficient
logP, used to quantify the lipophilicity and to predict drug transport
across biological membranes was reported to be 2.20 for pravastatin,
which is the lowest value among the 3 drugs and indicates the weakest
affinity for hydrophobic part of themonolayer [13]. Fluvastatin (logP=
4.50) and cerivastatin (logP = 3,40–4.15) contain aromatic rings in
their structures, which increase their lipophilicity [13,16]. The above
statins also differ in pKa values. The pKa value for pravastatin is 4.36,
for fluvastatin 4.15 [13]. However, for cerivastatin two pKa values are
distinguished, pKa1 is 4.38 for the carboxylic acid form, while pKa2 for
the pyridine form is 5.29 [17]. The investigated lipid monolayers consist
of 3 common lipids. DMPC molecules are neutral with their polar head
consisting of the uncharged choline. DMPE differs from DMPC in the
structure of polar head - the hydrophilic part is less hydrated than the
choline group and the NH3+ and PO4− groups interact forming hydrogen
bonds. DMPS is a molecule with a negatively charged headgroup under
conditions of our work [18,19]. Since the fatty acid residues are the
same, the effect of polarity, charge and hydration of the lipid
headgroups in themonolayer on the binding of statins can be compared.
The molecular alterations of the lipid monolayer organization are eluci-
dated using a combined approach involving measurements of surface
pressure, Brewster angle microscopy and PM-IRRAS. Understanding of
the effect of statins on the lipid component of the membrane is impor-
tant for the appropriate treatment for hypercholesterolemia, choice of





dimyristoyl-sn-glycero-3-phospho-L-serine (DMPS) were pur-
chased from Avanti Polar Lipids (USA). High purity and anhydrous
solvents: chloroform and methanol were used, both obtained from
Sigma Aldrich (Poland). DMPC solution was prepared in chloroform,
while DMPE and DMPS were dissolved in chloroform/methanol 4:1
v/v. Either pure water or phosphate-buffer saline (PBS) solution of
pH 7.4 and concentration 0.01 M corresponding to the physiological
conditions was used as the subphase. Pravastatin, fluvastatin and
cerivastatin purchased from Sigma Aldrich were of high purity
≥98%. They were dissolved in water/PBS buffer subphase in order to
obtain solutions at three concentrations (10−6, 5·10−6 and
10−5 M). The concentration values were chosen based on other stud-
ies on statin-lipid interactions as well as on in vitro studies on the
possible statins' anticancer effect on human ovarian cancer cell




The experimentswere carried out using KSV-Nima Langmuir trough
with Wilhelmy microbalance. The setup consists of two moveable, hy-
drophilic barriers and hydrophobic troughs of total areas of either
243 cm2 or 587 cm2. After careful cleaning of the troughwithmethanol
and chloroform and rinsingwith plenty ofwater, the phospholipid solu-
tions in chloroform or chloroform:methanol 4:1 v/v were deposited on
pre-cleaned surface of the subphase by a Hamilton syringe (50 μl or
100 μm). After that, organic solvent evaporation was allowed for
10 min. The measurement of surface pressure (±0.1 mN/m) was per-
formed using filter paper as the Wilhelmy plate connected with the
Wilhelmy balance. All experiments were carried out at room tempera-
ture (21 ± 1 °C).
2.2.2. Brewster angle microscopy (BAM)
Brewster angle microscopy images were recorded using UltraBAM
with Nanofilm_ep3 setup (Accurion, Germany). BAM images were
taken simultaneously with the measurement of surface pressure –
area per molecule (π-A) isotherm. The actual size of the photographed
area of monolayer is 800 μm × 430 μm.
2.2.3. Polarization modulation infrared reflection absorption spectroscopy
(PM-IRRAS)
PM-IRRAS experimentswere carried out using trough of total area of
243 cm2 and KSV-Nima software. A KSV-Nima PM-IRRAS (PMI 550)
spectrometer was applied. The light beam (He-laser and IR) reached
the air/water surface at the angle of 76o, the measurement range
expressed in the wavenumber was between 700 cm−1 and
4000 cm−1with the resolution of 8 cm−1. Onone armof the goniometer
there is an FTIR spectrometer with ZnSe polarization modulation unit
(Hinds Instrument, USA), which was set to 1500 cm−1 to ensure its
maximum efficiency in the polar head group region and on the other
arm there is the MCT detector. The light was constantly modulated
between the polarization p and s, so that the difference of the above-
mentioned signals gives the signal for surface and their sum – the refer-
ence spectrum. If S is thefinal spectrum, it is defined as S= δ/σ, where δ
is difference of Rs and Rp (reflectivities of the s and p beam, respectively)
and σ is the sum of the detected reflectivities of the p- and s- polarized
light. Each measurement consisted of 3000 scans, thus the measure-
ment time was 5 min. Before each measurement the background mea-
surement for the pure subphase without phospholipid was performed.
Each final spectrum was normalized, which was done by applying the
following formula:
ΔS ¼ Sπ−S0ð Þ=S0; ð1Þ
where Sπ is the spectrum of monolayer and S0 is the background
spectrum. Such background-corrected spectra are reported in this man-
uscript. Additionally, the PM-IRRAS spectra were also baseline-
corrected. The measurements were made at the surface pressure of 30
mN/m, which was kept constant during the collection of the spectra.
3. Results and discussion
3.1. Langmuir monolayer studies of the interactions of statins with phos-
pholipid membranes
In order to assess the effect of the three selected statins on themodel
phospholipid membranes the Langmuir experiments at the air-water
interface were performed. As mentioned above, the model systems
were two zwitterionic lipids (DMPC and DMPE) and one negativelycharged lipid (DMPS). The drugs were dissolved in the subphase, on
which the phospholipid monolayers were formed. The changes in the
isotherm shapes and characteristic parameters due to the interactions
with drugs were followed.
The surface pressure-area per molecule isotherms for the DMPC
monolayer were recorded for the pure PBS buffer subphase or water
and following the addition of statins: pravastatin, fluvastatin and
cerivastatin (Figs. 2A and S1). The differences between isothermparam-
eters are collected in Table 1. DMPC is a neutral lipidwith the uncharged
choline and the film prepared on pure PBS buffer is in a liquid-expanded
phase. The compressibility modulus allows one to describe the state of




The Cs−1max value equal to 80 mN/m confirms the liquid-expanded
form of the monolayer in agreement with the literature data (Fig. 2A
and Table 1) [18].
The presence of each of the statins in the subphase caused a shift of
the isotherms towards higher areas per molecule, as indicated by the
value of the area, atwhich the “lift-off”point is seen. The largest changes
are thus observed at small surface pressures, i.e. at early stages ofmono-
layer formation. Although interactions of all statins with
phosphocholine monolayers were visible by the changes of the iso-
therms in all cases, the largest increase in A0 together with a significant
increase in membrane fluidity are observed for fluvastatin (Fig. 2A and
Table 1). Fluvastatin remains in the monolayer up to high surface pres-
sures leading to the fluidization of the original monolayer. For
cerivastatin a significant difference in the isothermal shape is observed
compared to that of the DMPC monolayer formed on pure buffer sub-
phase (Fig. 2A). Surface pressure begins to increase already at very
large area per molecule values and the compression modulus decreases
relative to that of theDMPCmonolayer on pure subphase to the value of
52.0 mN/m indicating a highly expanded liquid phase (LE) [23]. In the
liquid-expanded phase, the lipid molecules interact with each other
mainly through polar heads and their hydrophobic tails are inclined at
different angles to the interface [24]. It may be supposed that
cerivastatin interacts with monolayer components mainly at the begin-
ning of the compression at large areas per molecule and upon further
compression it is expelled from the phospholipid monolayer, since the
isotherm overlaps with the DMPC isotherm on pure buffer. The effect
of pravastatin, which is the most hydrophilic drug, is almost negligible,
as if it only slightly interactedwith polar choline heads, not affecting the
organization of the nonpolar part of the monolayer. Interestingly, there
are no significant changes in the effect of the selected statins when the
subphase is changed from PBS buffer to pure water (Fig. S1A and
Table S1).
As described in the Introduction, DMPE differs from DMPC in the
structure of polar head (Fig. 1), thus the hydrophilic part of this lipid
is less hydrated than in the choline lipid [19]. In the case of DMPEmono-
layer formed on pure buffer, awell-developed phase transition is visible,
which indicates the change of phase from LE to LC (Fig. 2B). The maxi-
mum value of compression modulus is 335 mN/m (Table 1), reflecting
the solid nature of the film at larger surface pressures [25]. Comparison
of the isotherms of DMPE monolayer in the presence of three statins in
the PBS subphase suggests that each of the statins interacts with etha-
nolamine lipid, however, in a different way. Pravastatin shows the
weakest effect upon the monolayer structure, although the shift of the
isotherm towards higher areas per molecule without changing the iso-
therm shape reflects some interaction or incorporation of the drug
into the layer (Fig. 2B). The increased lipophilicity of fluvastatin and
cerivastatin compared to pravastatin as indicated by logP values
[13,16] and also logD (distribution of the drug in octanol:water at phys-
iological pH= 7.4) values [26] significantly facilitates interactions with
hydrophobic chains of the fatty acid residues. As a result, the surface
Fig. 2. Surface pressure – area permolecule (π-A) isotherms of A)DMPC; B)DMPE; C)DMPSmonolayers formed onpure PBS buffer solution (black/1) andD)DMPSmonolayers formed on
pure water (black/1) and subphase containing 10−5 M pravastatin (red/2), 10−5 M fluvastatin (green/3) and 10−5 M cerivastatin (blue/4). Insets: compression modulus vs surface
pressure plot. (T = 21 ± 1 °C). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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m) in the presence of fluvastatin, which suggests stronger interactions
of this drug with model DMPE monolayer. As with DMPC, cerivastatin
gets incorporated already at large areas per molecule and surfaceTable 1
Characteristic parameters of DMPC, DMPE and DMPS Langmuir monolayers formed on sub
cerivastatin (CER).
Subphase A0 (Å2) A30 mN/m (Å2)
DMPC
PBS pH = 7.4 78.5 ± 2.3 56.1 ± 0.7
10−5 M PRA 90.7 ± 4.0 57.9 ± 1.2
10−5 M FLU 112.8 ± 9.6 70.2 ± 4.8
10−5 M CER 89.9 ± 0.8 57.0 ± 2.9
DMPE
PBS pH = 7.4 51.1 ± 0.3 45.2 ± 0.3
10−5 M PRA 54.5 ± 0.9 46.6 ± 1.0
10−5 M FLU 60.3 ± 0.0 49.7 ± 0.0
10−5 M CER 57.4 ± 1.0 50.3 ± 0.9
DMPS
PBS pH = 7.4 50.9 ± 0.7 45.4 ± 0.0
10−5 M PRA 52.2 ± 0.5 47.0 ± 2.1
10−5 M FLU 58.9 ± 0.3 50.9 ± 1.4
10−5 M CER 50.8 ± 0.7 41.2 ± 0.6pressure at first slowly increases (Fig. 2B). However, cerivastatin causes
relatively small changes of A0 and Cs−1 (Table 1). Again, fluvastatin has
the greater impact on lipid organization, as its addition causes the larg-
est increase in A0 value and largest decrease in the compressionphases containing 10−5 M concentrations of pravastatin (PRA), fluvastatin (FLU) and
Acoll (Å2) πcoll (mN/m) Cs−1 (mN/m)
38.5 ± 0.3 46.6 ± 0.6 80 ± 1
39.5 ± 0.7 44.9 ± 1.7 65 ± 3
44.3 ± 1.2 45.2 ± 1.1 55 ± 6
44.2 ± 5.9 46.2 ± 5.9 52 ± 12
37.9 ± 0.8 56.1 ± 1.8 335 ± 9
40.2 ± 1.2 53.1 ± 0.9 248 ± 1
35.9 ± 0.4 59.7 ± 1.7 153 ± 7
37.4 ± 3.9 59.0 ± 0.8 211 ± 5
32.4 ± 0.4 65.6 ± 1.1 305 ± 1
32.1 ± 0.4 64.3 ± 0.2 152 ± 4
34.6 ± 0.9 61.7 ± 3.5 136 ± 3
24.8 ± 0.5 65.0 ± 3.0 206 ± 5
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phase to a less condensed (Table 1). According to the literature,
fluvastatin may locate in the hydrophobic part of the membrane in an
intermediate position in the upper region of the acyl chains, while
cerivastatin may penetrate deeper the hydrophobic chains region [21].
The above-mentioned location of fluvastatin would result in the
changes in the area per molecule as well as in the increase in themem-
brane fluidity as observed in Langmuir studies. The less pronounced ef-
fect of cerivastatin on the A0 and Cs−1 may indicate that cerivastatin as
the most hydrophobic drug easily penetrates the layers. Interestingly,
the observed effect of statins on DMPE membranes does not depend
on the subphase composition and was similar for monolayers formed
on water (Fig. S1B and Table S1).
In order to get more insight into the effect of statins on themorphol-
ogy of phospholipid monolayers Brewster angle microscopy has been
also employed. The BAM images show clearly the different behavior of
theDMPEmonolayer compressed on subphases containing cerivastatin,
fluvastatin and pravastatin (Fig. 3). The formation of typical, large
flower-shaped domains can be observed for DMPE monolayers formed
on pure buffer subphase. The domains appear at surface pressure of 10Fig. 3. BAM pictures obtained at selected surface pressures for DMPEmonolayers formed on PB
100 μm.mN/m, which corresponds to the LE-LC phase transition. The domain
formation in the case of cerivastatin appears at similar surface pressures
as for DMPE layer compressed on pure subphase, but their shape is al-
tered and they become smaller. This effect becomes even more pro-
nounced with further compression of the monolayer – the domains
observed at 15 mN/m are small and round and finally coalesce to form
more uniformmonolayer. In the case of fluvastatin presence in the sub-
phase, DMPE domains preserve their typical shape although are smaller
and they start to appear at higher surface pressures compared to DMPE
monolayer on pure buffer subphase. This also proves that fluvastatin
fluidizes the monolayer so that the phase transition appears at much
higher surface pressures. Weaker but similar effect is seen in the case
of the hydrophilic pravastatin acting as a slightly fluidizing agent upon
the DMPE monolayer: the domain formation and phase transition is
only slightly affected. The BAM images are consistent with the result
of the surface pressure – area per molecule isotherms.
The influence of different concentrations of statins on the properties
of DMPE monolayers has been also investigated (Fig. S2). In the case of
pravastatin, no significant differences in the isotherm characteristics
were observed for different concentrations of this drug in the subphase.S buffer pH 7.4 and PBS pH 7.4 containing 10−5 M statins. (T=21± 1 °C). The scale bar is
Fig. 4. PM-IRRAS spectra in the ~1800 cm−1 to ~800 cm−1 region of DMPC monolayers
compressed to 30 mN/m on pure water subphase (black/1) and water subphase
containing 10−5 M pravastatin (red/2), 10−5 M fluvastatin (green/3), 10−5 M
cerivastatin (blue/4). (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
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molecule, while preserving their shape. For fluvastatin the shape of
the isotherm remains very similar with the increasing concentration,
but the surface pressure of the phase transition increases with
fluvastatin concentration. In the same time the maximum value of
Cs−1 decreases (Table S2). However, these changes are not directly pro-
portional to the drug concentration. Thefluidization of theDMPEmono-
layer in the presence of cerivastatin is not concentration-dependent,
since the maximum value of compression modulus is comparable irre-
spective of the cerivastatin concentration and implies only that the
monolayer changes its phase from solid to liquid condensed (Table S2).
The third model system used to study interactions with statins em-
ploys DMPS, which is a phospholipid with a negative charge due to
the presence of the serine in the polar head (Fig. 1). The DMPS mono-
layers are characterized by strong packing of lipid polar heads with
acyl chains adopting orientation close to perpendicular to the air-
water interface, which results in relatively low values of area per mole-
cule in the well-organized monolayer [19,27]. Additionally, a plateau
corresponding to LE-LC phase transition is clearly visible (Fig. 2C, D
and Tables 1 and S1). DMPS monolayers also exhibit relatively high
values of compression modulus corresponding to solid monolayer
state [18]. However, it should be kept in mind that the negatively
charged DMPS monolayer shows slightly different surface properties
depending on the composition of the subphase, since the negatively
charged polar heads of PS lipids interact electrostatically with the
monovalent cations [28]. Therefore, the effect of the change of the sub-
phase from water to buffer leads also to the differences in the effect of
statins observed for the DMPS monolayer. The results obtained for the
two types of subphases: water and buffer are compared (Fig. 2C, D).
When pure water is used as a subphase, the influence of pravastatin
on DMPS monolayers is almost negligible (Fig. 2D). The presence of
fluvastatin leads to the shift of the surface pressure of phase transition
to the higher values and to the significant decrease in the maximum
value of compression modulus, which proves the fluidizing effect of
the drug. The most significant changes are observed for cerivastatin.
The area per molecule increases significantly and the maximum value
of compression modulus decreases (Table S1). Additionally, the shape
of the isotherm changes, since the plateau region corresponding to the
phase transition is no longer clearly visible (Fig. 2D). In the case of the
application of PBS buffer as a subphase, the phase transition region is
shifted to a higher surface pressure of almost the samevalue in the pres-
ence of both pravastatin and fluvastatin showing similar effect of these
two drugs (Fig. 2C). Additionally, the shapes of the isotherms are also
very similar. The biggest increase in the area per molecule (58.9 Å2)
and the largest decrease in compression modulus value (135.8 mN/m)
is observed for fluvastatin (Table 1). This confirms the increase in fluid-
ity. Cerivastatin behaves again in a different way: the isotherm shape
changes significantly, the region of phase transition appears at lower
surface pressures than on the pure subphase, and the maximum value
of compression modulus is smaller suggesting that the layer changed
its state from solid to liquid condensed (Table 1). However, this value
is still significantly higher than the values obtained in the presence of
pravastatin or fluvastatin.
The effect of different concentrations of the statins on DMPS mono-
layers formed on buffer subphase depends on the statin. The addition of
pravastatin into the subphase does not change the shape of the iso-
therms significantly (Fig. S3). However, the presence of higher
cerivastatin concentrations leads to unexpected changes in the struc-
ture of DMPS layers: the value of area per molecule at 30 mN/m be-
comes smaller than that for DMPS monolayer formed on pure buffer,
and themaximum Cs−1 values are distinctly larger than in the presence
of similar concentrations of the other two drugs (Fig. S3, Table S2). Thus,
there is a clearly solidifying effect at higher concentrations of this statin,
which resembles the influence of cholesterol upon the lipid layers. Such
an ordering effect on the lipid membranes due to the presence of
molecules possessing rigid, steroid-like moiety in the structure hasbeen previously observed for example for a glyco-diosgenin, a synthetic
surfactant [29]. Therefore, a similarity of cerivastatin to cholesterol
should be taken into consideration in view of any applications of this
statin as the cholesterol lowering drug, since substitution of cholesterol
by cerivastatin may be another function of this drug apart from its role
as the inhibitor of HMG-CoA reductase. Additionally, BAM images
show themost homogenous layer at 30mN/m in the case of cerivastatin
in the subphase (Fig. S4).3.2. PM-IRRAS studies of statins interactions with model membranes on
water subphase
PM-IRRAS spectra provide useful information on the interactions of
solution species with polar head groups of phospholipids. The spectra
were collected in the presence of the three selected statins dissolved
in the water subphase to obtain the final concentration of 10−5 M and
compared with spectra collected for a phospholipid monolayer formed
on pure water subphase. The water subphase was chosen due to the
fact that for the two neutral lipids (DMPC and DMPE) no significant dif-
ferences in the nature of the interactions of statinswere observedwhen
water subphase was exchanged to buffer. In the case of negatively
charged DMPS monolayers the application of pure water subphase for
PM-IRRAS studies allowed us to focus on the interactions of statins
with polar head groups without interfering effect of cations present in
the buffer solution, since it has been previously shown that the presence
of salts may interfere with the interactions between statins and phos-
pholipids [12]. Our intention was to investigate the effect of statins on
lipid monolayers that mimic biological membranes. Therefore, prior to
PM-IRRAS measurements, the phospholipid monolayers were com-
pressed to 30 mN/m, at which lipid monolayers and bilayers are in cor-
responding states and the molecular organization and elastic
compressibility modulus for monolayers and bilayers are comparable
[30–32].
The spectra of the two regions corresponding to the polar head
group (phosphate group) region between 1300 cm−1 and 1000 cm−1
and ester group region centered at ~1700 cm−1 were collected. Fig. 4
shows the spectra collected between ~1800 cm−1 and ~800 cm−1 for
7M. Zaborowska et al. / Journal of Molecular Liquids 313 (2020) 113570DMPC monolayers compressed to 30 mN/m on pure water and water
containing three selected statins.
The first interesting spectral region centered at ~1700 cm−1 refers to
the ester carbonyl group. The υ(C=O) band position is sensitive to the
hydrogen bonding [33,34]. The maxima observed at 1740 cm−1-
correspond to the non-hydrogen bonded ester groups, while shift of
the band to the lower wavenumbers corresponds to the hydrogen-
bonded groups. In the case of DMPC monolayers formed on pure
water ester groups are mostly non-hydrated, since the band maximum
at 1744 cm−1 is observed (Table 2). The band shift towards lower
wavenumbers in the presence of pravastatin and fluvastatin is observed
but it is within the spectral resolution of the equipment (8 cm−1). It
should be also noted that another band below 1700 cm−1 develops.
Due to its position it may be attributed to the hydrogen-bonded compo-
nent of the C_O band. Therefore, it may by postulated that the ester
carbonyl group gets involved in the interaction with statins' OH group.
Such interactions are favored for the most hydrophilic pravastatin and
therefore this band is the most evident in the presence of this drug. In
the case of cerivastatin the υ(C=O) band position is equal to
1712 cm−1, which proves strong hydrogen bonding of the DMPC ester
group due to the presence of this statin.
Another useful spectral region between 1300 cm−1 and 1000 cm−1
provides information on the phosphate group. The position of both
symmetric and asymmetric bands and the broadening of the υas(PO2−)
band located ~1230 cm−1 implies hydration of phosphate group. It is
observed for both DMPC monolayer on pure water and on subphases
containing statins. However, for fluvastatin and especially for
cerivastatin a slight shift of the band position to lower wavenumbers
is observed (Table 2). It suggests the increasing hydration of phosphate
group compared to pure DMPC monolayers [33,34]. There is also an-
other band observed in this spectral region located usually between
~1170 cm−1 and ~ 1180 cm−1. This band corresponds to the asymmet-
ric C-O-C stretch of the ester groups in the β and γ acyl chains of DMPC,
υas(C-O-C) [34]. According to the literature, the position of this band at
~1180 cm−1 corresponds to the planar orientation of C-O-C group in γ
acyl chain [35]. The shift of this band to lower wavenumbers
~1165 cm−1 signifies non-planar orientation of β acyl chain. Based on
the data summarized in Table 2 itmay be stated that the non-planar ori-
entation prevails in the case of pravastatin and fluvastatin presence in
the DMPC monolayer, while for cerivastatin probably the planar orien-
tation of the chain dominates. Other bands can be also distinguished be-
tween 1050 cm−1 and 1030 cm−1 depending on the investigated
system (Fig. 4). These bandsmay be attributed to the asymmetric single
bond C\\O stretch of the ester phosphate group vas(C-O[P]) at
~1050 cm−1 [36,37]. The exact position of these bands differs for
DMPC in the absence and presence of statins. It is difficult to draw con-
clusion due to the uncertainty of the exact band position but undoubt-
edly this band becomes much better developed when cerivastatin is
present in the monolayer, which also means that the drug interacts
with polar head group region of DMPC molecules.
The analysis of the position of bands corresponding to the vibrations
within choline group of DMPCmolecule in the 1000–800 cm−1 spectral
region, where C-N-C stretching bands are located, allows for obtainingTable 2
PM-IRRAS band position (in cm−1) for DMPCmonolayers formed onwater and subphases
containing 10−5 M concentrations of pravastatin (PRA), fluvastatin (FLU) and cerivastatin
(CER).
Band DMPC DMPC + PRA DMPC + FLU DMPC + CER
υ(C=O) 1744 1736 1736 1712
υas(PO2−) 1234 1226 1219 1219
υas(C-O-C) 1170 1165 1157 1180
υs(PO2−) 1080 1072 1087 1072
υas(CN+(CH3)3) 964 964 979 956
υs(CN+(CH3)3) 925 – 925 902
879 879 895 –the information on the conformation of the O-C-C-N frame of the cho-
line group. This group can assume trans conformation, when bands cor-
responding to υs(CN+(CH3)3) are observed at ~925 cm−1
and ~ 875 cm−1. Trans conformation occurs for dry films. The positions
of these bands at ~900 cm−1 and ~ 860 cm−1 correspond to the gauche
conformation typical for hydratedfilms [38]. The other pair of bands ob-
served at ~970 cm−1 and ~ 950 cm−1 are attributed to the υas
(CN+(CH3)3) vibrations [33]. Additionally, there might be also a band
corresponding to the asymmetric PO single bond, which occurs at
~825 cm−1 [38]. However, band assignment in the lowwavenumber re-
gion is difficult due to the low efficiency of PEM. In the case of DMPC
monolayer formed on pure water subphase the band position observed
for symmetric stretchingυas(CN+(CH3)3) clearly suggests the trans con-
formation of the choline frame (Table 2). Similar situation occurs for
DMPC monolayers in the presence of pravastatin and fluvastatin,
which show similar band positions to the pure DMPC monolayers, al-
though not all bands arewell developed for pravastatin and the band as-
signment is difficult for the lower wavenumber component for
fluvastatin (Fig. 4). However, a different situation is observed for
cerivastatin. In the presence of this drug in the DMPC monolayer com-
pressed to 30 mN/m the asymmetric band is significantly shifted to-
wards lower wavenumbers, ~902 cm−1 (Table 2). The second
component of the symmetric stretching cannot be univocally assigned
because the assignment of the intense band at ~840 cm−1 is difficult.
However, it implies that the O-C-C-N frame of the choline group in
this case is in gauche conformation. Therefore, it may be concluded
that among the investigated statins only cerivastatin is able to interact
strongly with choline group of DMPC, which results in the change in
its conformation from trans to gauche.
Overall, it may be stated that among all the three investigated statins
the most significant differences may be observed for the DMPC polar
head and ester group region for DMPC monolayers in the presence of
cerivastatin. This drug imposes changes in the conformation of choline
group, increases hydration of phosphate and ester carbonyl group and
influences the orientation of C-O-C group of acyl chains. It all proves
the interactions of cerivastatin with DMPC and influences the confor-
mation of the phospholipid molecules. Fluvastatin interacts mostly
with phosphate group leading to its increased hydration, while the ef-
fect of pravastatin is not that significant.
As mentioned above, DMPC and DMPE molecules both have overall
neutral charge (Fig. 1) but the three nitrogen-bound methyl groups of
the DMPC polar head in DMPE are replaced by three hydrogen atoms
[19]. Thus, the DMPE head group is less hydrated than that of DMPC.
Fig. 5 shows the spectra recorded for DMPEmonolayers formed on sub-
phases containing the studied drugs.
In the spectral region around1700 cm−1 there is a strong signal from
the carbonyl group in the ester group at 1735 cm−1 [39]. The bands cor-
responding to υ(C=O) are well developed both for DMPE on a pure
water subphase and with the addition of statins. Similar values have
been obtained for the spectra (1736 cm−1), except for the monolayer
formed on the subphase with cerivastatin, since this value is slightly
shifted towards higher wavenumbers compared to DMPE on pure sub-
phase but the change remains within the resolution limit (Table 3).
Therefore, it may be concluded that the ester group of DMPE remains
non-hydrated in the presence of statins.
In the spectral region of the phosphate group vibration symmetric
(υs(PO2−)) and asymmetric (υas(PO2−)) vibrations at 1090 cm−1 and
1230 cm−1 are observed, respectively [33]. The position of these
bands suggests the hydration of phosphate group both in pure DMPE
monolayers and monolayers in the presence of all statins. The wave-
number, at which symmetrical vibrations occur, have similar values
(~1080 cm−1), except for the monolayer formed on subphase contain-
ing pravastatin, when this band is observed at 1073 cm−1 (Table 3). It
may suggest that pravastatin induces slightly increased hydration of
phosphate group. Some shift of the vas(C-O[P]) band is also observed
in the presence of pravastatin (Table 3).
Fig. 5. PM-IRRAS spectra in the ~1800 cm−1 to ~800 cm−1 region of DMPE monolayers
compressed to 30 mN/m on pure water subphase (black/1) and water subphase
containing 10−5 M pravastatin (red/2), 10−5 M fluvastatin (green/3), 10−5 M
cerivastatin (blue/4). (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
Table 3
PM-IRRAS band position (in cm−1) for DMPEmonolayers formed onwater and subphases
containing 10−5 M pravastatin (PRA), fluvastatin (FLU) and cerivastatin (CER).
Band DMPE DMPE + PRA DMPE + FLU DMPE + CER
υ(C=O) 1736 1736 1736 1740
υas(PO2−) 1219 1226 1216 1214
υas(C-O-C) 1154 1162 1159 1167
υs(PO2−) 1082 1073 1083 1078
υas(C-O[P]) 1026 1036 1026 1023
Fig. 6. PM-IRRAS spectra in the ~1800 cm−1 to ~800 cm−1 region of DMPS monolayers
compressed to 30 mN/m on pure water subphase (black/1) and water subphase
containing 10−5 M pravastatin (red/2), 10−5 M fluvastatin (green/3), 10−5 M
cerivastatin (blue/4). (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
Table 4
PM-IRRAS band position (in cm−1) for DMPSmonolayers formed onwater and subphases
containing 10−5 M concentrations of pravastatin (PRA), fluvastatin (FLU) and cerivastatin
(CER).
Band DMPS DMPS + PRA DMPS + FLU DMPS + CER
υ(C=O) 1736 1736 1736 1743
υas(PO2−) 1219 1211 1211 1234
υas(C-O-C) 1172 1165 1165 1140
υs(PO2−) 1087 1080 – 1103
υs(C-O[P]) 1049 1033 1041 1049
υas(P-O) 833 – 841 833
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statin interacts with polar head group of DMPE, especially with phos-
phate group causing its increased hydration. Interestingly, for more
hydrophobic drugs such as fluvastatin and cerivastatin no significant
changes in the spectra in polar head group region are observed com-
pared to DMPE monolayer on pure water. It suggests that those drugs
do not impose any changes in the orientation of polar head group com-
ponents. On the other hand, the changes in the DMPE isotherms were
observed in the presence of these two drugs (Fig. S1B) suggesting
some interactions. The PM-IRRAS results may support the explanation
given based on literature data suggesting that fluvastatin may be lo-
cated in the lower part of acyl chains [21]. Cerivastatin might be either
penetrating the layers, not affecting heavily the orientation of polar
heads at the air-water interface or might be partially removed from
the layer underneath the polar heads of DMPE. Clearly, the effect of
statins on DMPE monolayers is different to that on DMPC monolayers
described above. It is again connected with the differences in the polar
head group region of these lipids resulting in the different hydration
and presence of hydrogen bonding between NH3+ and PO4− groups of
DMPEmolecules,which in turn prevents the statins from stronger inter-
actions with DMPE polar heads.
In the case of DMPS monolayers on the water subphase similar
bands as for DMPCandDMPE can be resolved both in the ester group re-
gion and phosphate group region (Fig. 6). In general, DMPS polar head
groups are not involved in intramolecular interactions characteristic
for DMPE (hydrogen bonding between NH3+ and PO4−), hence they aremore hydrated than ethanolamine polar group [40]. Most significant
changes occur in this case for solutions containing cerivastatin (Table 4).
In the presence of cerivastatin the υ(C=O) band is slightly shifted to
higher wavenumbers compared to pure DMPSmonolayer. It implies the
decrease in the hydration of the ester group. It is also interesting to note
that the lower-wavenumber component of C_O band located at
1712 cm−1 is well developed in this case. The same trend is observed
for phosphate group bands located at ~1230 cm−1 and ~1090 cm−1,
which correspond to υas(PO2−) and υs(PO2−) band, respectively
(Table 4). The position of these bands, especially the asymmetric one,
for pure DMPS monolayer implies that phosphate groups are hydrated
[33,34]. The presence of pravastatin and fluvastatin leads to the shift
of the asymmetric band position towards slightly lower wavenumbers,
which suggest even more hydration. However, cerivastatin induces op-
posite changes. The υas(PO2−) band is significantly shifted towards
higher wavenumbers proving the dehydration of phosphate group.
Consistently, the other band corresponding to phosphate group, υs
(PO2−), is also shifted towards higher wavenumbers in the presence of
cerivastatin (Table 4). These changes are similar to the effects observed
for the interactions of PS lipids with divalent cations such as Ca2+ re-
ported by Binder et al. [41] and Casal et al. [42]. The shifts of the bands
were suggested to result from the interactions with calcium cations
and dehydration of the phosphate group. The bands are shifted to
higher wavenumbers and become narrower, which is associated with
the reduction in motional freedom, leading to the immobilization of
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made with respect to ester carbonyl group. The C_O bands became
split giving rise to two components, similar to those observed in the
case of cerivastatin (Fig. 6). Based on the above mentioned literature,
there is another band, which is typical for PS groups and which might
be also affected, namely the band due to the COO− antisymmetric
stretchingmode located at 1620 cm−1 [42,43]. It has been previously re-
ported that fluvastatin interacts through COO− groups with mixed
DMPC/DMPS bilayers causing a shift of this band to lower
wavenumbers, which proves the formation of H-bonds between this
group and polar moieties of the drug [12]. Unfortunately, in our case
this band is not well developed. The band assignment and any compar-
ison of the interactions of three statins with this part of DMPSmolecule
through hydrogen bonding is thus rather difficult (Fig. 6).
It may be concluded that the mechanism of cerivastatin interactions
with DMPS polar head groups may be comparable to that of divalent
cations such as Ca2+, which consists in the removal of water of hydra-
tion from the phosphate and ester carbonyl groups. This mechanism is
opposite to the one observed for DMPC monolayers, in the case of
which increased hydration of the initially less hydrated choline and
ester groups in the presence of cerivastatin was observed. These results
stay in good agreement with the Langmuir monolayer studies. The re-
duction inmotional freedom and the immobilization of the entire phos-
pholipid polar group in the presence of cerivastatin results in the overall
increase in the monolayer order, which is shown by the increase in the
compressionmodulus values (Fig. 2D). On the other hand, the increased
hydration of polar head group region of DMPS in the presence of prava-
statin and fluvastatin leads to the increased overall fluidization of the
DMPS monolayer and thus decrease in the Cs−1 value.
In this work we focus on the PM-IRRAS analysis of the polar
headgroup part of lipid monolayers exposed to statins and therefore
the experimental conditions were optimized for this IR region
(Section 2.1). However, the analysis of the CH stretching region be-
tween 3000 and 2800 cm−1 may provide information on the changes
in the orientation and conformation of the acyl chains (Fig. S5). The po-
sitions of the methylene symmetric and asymmetric bands provide in-
formation on the acyl chain conformation. The values lower than
2920 cm−1 and 2850 cm−1 for υas(CH2) and υs(CH2), respectively indi-
cate that acyl chains are fully stretched and assume all-trans conforma-
tion [33,44]. Such a situation can be observed for both DMPE and DMPS
monolayers formed on pure water subphase, since the methylene
asymmetric and symmetric bands are located at ~2916 cm−1 and
~2847 cm−1 for both phospholipids (Fig. S5). These results are consis-
tentwith the PM-IRRAS data obtained for DMPS andDMPE bilayers sup-
ported on Au(111) electrodes [40]. However, when statins are present
in the subphase, the general trend of the shift of the asymmetric band
location towards higherwavenumbers (2924 cm−1) can be noticed. Ad-
ditionally, the tendency to increase the band width in the presence of
statins can be observed. It all may indicate the increasing presence of
gauche conformation and melting of the chains. Despite the fact that
the above mentioned changes in the band location and width are
close to the spectral resolution of the equipment and therefore can be
only treated as general statements, these results are consistent with
the conclusions drawn from the changes in the compression modulus
(Figs. 2 and S1). The interactions of statins with both DMPE and DMPS
monolayers lead to the decrease in the Cs−1 values, which points out
to the fluidization of the monolayer. The only exemption is the effect
of pravastatin on DMPS monolayers, when Cs−1 remains the same. It
is also reflected by very similar PM-IRRAS spectra in the CH stretching
region for DMPS on pure water and in the presence of pravastatin
(Fig. S5C). In the case of DMPC monolayer, the band location obtained
for DMPC on pure water is already shifted towards higher frequencies
(2924 cm−1 and 2854 cm−1, respectively), which is again consistent
with PM-IRRAS literature data for supported DMPC bilayers [33]. It
also stays in agreement with the values of Cs−1 showing that DMPC
monolayers are in the liquid-expanded state. Pravastatin presence inthe subphase leads to the slight increase in the Cs−1 value (Fig. S1 and
Table S1) and thus to the shift of the band position towards lower fre-
quencies (Fig. S5A), while fluvastatin and cerivastatin slightly decreases
Cs−1 values and consequently moves the band positions again towards
higher frequencies.
4. Conclusions
The surface pressure – area per molecule measurements allowed us
to monitor the effect of three different statins on the structure of mono-
layers formedby the selected phospholipids. The results of those studies
showed the degree of incorporation of the drugs into the layers and
changes in the properties of the monolayers such as the liquid/solid
phase transitions and stability upon compression in the presence of
the drugs. On the other hand, the PM-IRRAS studies revealed the effect
of the selected drugs on the polar head group region of the lipid layers
and allowed us to explain the changes of the full monolayer properties
observed using the Langmuir method. The BAM images confirm the re-
sults of the surface pressure – area permolecule isotherms proving that
statins significantly alter the morphology of the layers leading to their
fluidization. The isotherms show clearly that in the presence of statins
the phase transitions present during the formation of the monolayers
at the air-solution interface are shifted to higher surface pressures,
which means that the less condensed form of the monolayer is favored
when the layer is exposed to these statins.
Cerivastatin affects strongly the structure and properties of lipid
monolayers and its behavior was found to depend on the degree of hy-
dration of the lipid head groups and their charge. Cerivastatin imposed
changes in the conformation of choline groups in the DMPCmonolayer.
The interactionswith choline result in the change of the choline confor-
mation from trans to gauche as confirmed by the shift of the band re-
lated to the –O-C-C-N frame of the choline group. This means that the
head group becomes more hydrated compared to the same layer ex-
posed to pure water subphase. PM-IRRAS studies revealed also the in-
teraction with the ester group of DMPC. Cerivastatin present in the
monolayer increased hydration of phosphate and ester carbonyl group
and modified the orientation of C-O-C group of the acyl chains. As sug-
gested based on the surface pressure measurements, the aromatic
groups of this statin allow for a deeper penetration of the drug into
the hydrophobic part of the membrane. This would make the drug
more effective in lowering LDL cholesterol levels. However, it would
also contribute to more negative side effects due to its deeper location
between the lipid tails. It may be connectedwith higher risks of rhabdo-
myolysis as suggested by Galiullina et al. [21,45,46] andmay be the rea-
son for resigning from using cerivastatin in the treatment of
hypercholesterolemia [47]. On the contrary, pravastatin and fluvastatin
were found not to affect the choline group conformation of DMPC and
the properties of themonolayers resembled those on pure aqueous sub-
phase. Pravastatin had larger effect upon monolayers that consisted of
lipids with less hydrated head groups and more involved in hydrogen
bonding or other molecular interactions. A good example are mono-
layers of DMPE. In this case the interactionswithmost hydrophilic prav-
astatin are the most pronounced and the change of respective
wavenumbers to lower values indicates higher hydration of the ester
phosphate groups suggesting that the most hydrophilic drug is mostly
active in the region of the head groups but does not affect significantly
the organization of the lipid chains in the monolayer.
Significant changes occur in the case of DMPSmonolayers especially
upon contact with solutions containing cerivastatin. The results of PM-
IRRAS studies are consistent with the Langmuir isotherm data. Interest-
ingly, the observed changes are similar to the effects reported for PS
lipids in the presence of divalent cations such as Ca2+ [41,42]. In these
reports, the shifts of the bands were suggested to result from dehydra-
tion of the phosphate group and ester carbonyl groups due to interac-
tions with calcium cations. Reduction in motional freedom, leading to
the immobilization of the entire negatively charged phospholipid
10 M. Zaborowska et al. / Journal of Molecular Liquids 313 (2020) 113570polar group and to the overall increase in themonolayer order reflected
by the increase in the compressionmodulus valuesmay also explain the
interactions with cerivastatin. This mechanism is opposite to that ob-
served in the case of DMPC monolayers, where the increased hydration
of the polar groups in thepresence of cerivastatin occurred. Itmaybe as-
cribed in the case of DMPS to the contribution of electrostatic interac-
tions between the negatively charged headgroups and the drug.
Interestingly, the other two statins, pravastatin and fluvastatin, do not
cause such significant changes in the degree of hydration of polar
heads of DMPS. Such strong dehydration effects may be dangerous for
the lipid membranes and may also be one of the reasons to avoid this
very effective statin especially when large doses and prolonged applica-
tions are needed.
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